<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>causal-variants on Lasseigne Lab</title>
    <link>/tags/causal-variants/</link>
    <description>Recent content in causal-variants on Lasseigne Lab</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en</language>
    <lastBuildDate>Mon, 16 Apr 2018 00:00:00 +0000</lastBuildDate>
    
	<atom:link href="/tags/causal-variants/index.xml" rel="self" type="application/rss+xml" />
    
    
    <item>
      <title>Causal variant identification in neurodegenerative disease</title>
      <link>/research-projects/pathogenic-variant-discovery/</link>
      <pubDate>Mon, 16 Apr 2018 00:00:00 +0000</pubDate>
      
      <guid>/research-projects/pathogenic-variant-discovery/</guid>
      <description>My first postdoc project was a highly collaborative effort with Drs. Rick Myers and Greg Cooper (HudsonAlpha), Liz Cirulli (Duke), David Goldstein (Columbia), and Biogen Idec to sequence almost 3,000 amyotrophic lateral sclerosis (ALS) patient exomes to identify new genes contributing to ALS risk. We confirmed several known ALS genes and identified TBK1 as a novel ALS gene, revealing a key role of the autophagic pathway in ALS etiology and suggesting specific targets for therapeutic intervention.</description>
    </item>
    
  </channel>
</rss>